Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

TGF-β and HGF transmit the signals through JNK-dependent Smad2/3 phosphorylation at the linker regions

Abstract

Although hepatocyte growth factor (HGF) can act synergistically or antagonistically with transforming growth factor-β (TGF-β) signaling, molecular mechanism of their crosstalk remains unknown. Using antibodies which selectively distinguished receptor-regulated Smads (R-Smads) phosphorylated at linker regions from those at C-terminal regions, we herein showed that either HGF or TGF-β treatment of normal stomach-origin cells activated the JNK pathway, thereafter inducing endogenous R-Smads phosphorylation at linker regions. However, the phosphorylation at their C-terminal regions was not induced by HGF treatment. The activated JNK could directly phosphorylate R-Smads in vitro at the same sites that were phosphorylated in response to TGF-β or HGF in vivo. Thus, the linker regions of R-Smads were the common phosphorylation sites for HGF and TGF-β signaling pathways. The phosphorylation induced by simultaneous treatment with HGF and TGF-β allowed R-Smads to associate with Smad4 and to translocate into the nucleus. JNK pathway involved HGF and TGF-β-mediated infiltration potency since a JNK inhibitor SP600125 caused the reduction of invasive capacity induced by HGF and TGF-β signals. Moreover, a combined treatment with HGF and TGF-β led to a potent increase in plasminogen activator inhibitor type 1 transcriptional activity through Smad3 phosphorylation at the linker region. In contrast, HGF treatment reduced TGF-β-dependent activation of p15INK4B promoter, in which Smad3 phosphorylation at the C-terminal region was involved. In conclusion, HGF and TGF-β transmit the signals through JNK-mediated R-Smads phosphorylation at linker regions.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

Abbreviations

ERK:

extracellular signal-regulated kinase

JNK:

c-Jun N-terminal kinase

MAPK:

mitogen-activated protein kinase

MEKK-1:

mitogen-activated protein kinase kinase kinase-1

PAI-1:

plasminogen activator inhibitor type 1

R-Smads:

receptor-regulated Smads

SAPK:

stress-activated protein kinase

TAK1:

TGF-β-activated kinase 1

TβRI:

TGF-β type I receptor

References

  • Brown JD, DiChiara MR, Anderson KR, Gimbrone Jr MA and Topper JN . (1999). J. Biol. Chem., 274, 8797–8805.

  • Davis RJ . (1993). J. Biol. Chem., 268, 14553–14556.

  • de Caestecker MP, Parks WT, Frank CJ, Castagnino P, Bottaro DP, Roberts AB and Lechleider RJ . (1998). Genes Dev., 12, 1587–1592.

  • Derynck R, Zhang Y and Feng XH . (1998). Cell, 95, 737–740.

  • Engel ME, McDonnell MA, Law BK and Moses HL . (1999). J. Biol. Chem., 274, 37413–37420.

  • Furukawa F, Matsuzaki K, Mori S, Tahashi Y, Yoshida K, Sugano Y, Yamagata H, Matsushita M, Seki T, Inagaki Y, Nishizawa M, Fujisawa J and Inoue K . (2003). Hepatology, 38, 879–889.

  • Gutierrez LS, Schulman A, Brito-Robinson T, Noria F, Ploplis VA and Castellino FJ . (2000). Cancer Res., 60, 5839–5847.

  • Hannon GJ and Beach D . (1994). Nature, 371, 257–261.

  • Heldin CH, Miyazono K and ten Dijke P . (1997). Nature, 390, 465–471.

  • Hill CS and Treisman R . (1995). Cell, 80, 199–211.

  • Hirashima Y, Kobayashi H, Suzuki M, Tanaka Y, Kanayama N and Terao T . (2003). J. Biol. Chem., 278, 26793–26802.

  • Hua X, Liu X, Ansari DO and Lodish HF . (1998). Genes Dev., 12, 3084–3095.

  • Jonk LJ, Itou S, Heldin CH, ten Dijke P and Kruijer W . (1998). J. Biol. Chem., 273, 21145–21152.

  • Kimelman D and Kirschner M . (1987). Cell, 51, 869–877.

  • Kobayashi I, Kawano S, Tsuji S, Matsui H, Nakama A, Sawaoka H, Masuda E, Takei Y, Nagano K, Fusamoto H, Ohno T, Fukutomi H and Kamada T . (1996). In Vitro Cell Dev. Biol. Anim., 32, 259–261.

  • Kretzschmar M, Doody J and Massagué J . (1997). Nature, 389, 618–622.

  • Kretzschmar M, Doody J, Timokhina I and Massagué J . (1999). Genes Dev., 13, 804–816.

  • Li J-M, Nichols MA, Chandrasekharan S, Xiong Y and Wang X-F . (1995). J. Biol. Chem., 270, 26750–26753.

  • Macías-Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L and Wrana JL . (1996). Cell, 87, 1215–1224.

  • Massagué J . (1998). Annu. Rev. Biochem., 67, 753–791.

  • Matsuzaki K, Date M, Furukawa F, Tahashi Y, Matsushita M, Sakitani K, Yamashiki N, Seki T, Saito H, Nishizawa M, Fujisawa J and Inoue K . (2000). Cancer Res., 60, 1394–1402.

  • Mulder KM . (2000). Cytokine Growth Factor Rev., 11, 23–35.

  • Nakao A, Afrakhte M, Morén A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin NE, Heldin CH and ten Dijke P . (1997). Nature, 389, 631–635.

  • Piek E, Ju WJ, Heyer J, Escalante-Alcalde D, Stewart CL, Weinstein M, Deng C, Kucherlapati R, Bottinger EP and Roberts AB . (2001). J. Biol. Chem., 276, 19945–19953.

  • Roberts AB, Anzano MA, Lamb LC, Smith JM and Sporn MB . (1981). Proc. Natl. Acad. Sci. USA, 78, 5339–5343.

  • Roberts AB, Anzano MA, Wakefield LM, Roche NS, Stern DF and Sporn MB . (1985). Proc. Natl. Acad. Sci. USA, 82, 119–123.

  • Roberts AB and Sporn MB . (1990). Peptide Growth Factors and Their Receptors, Part I, Vol 95 Sporn MB and Roberts AB. (eds). Springer-Verlag: Berlin, pp. 419−472.

    Google Scholar 

  • Robinson MJ and Cobb MH . (1997). Curr. Opin. Cell Biol., 9, 180–186.

  • Sano Y, Harada J, Tashiro S, Gotoh-Mandeville R, Maekawa T and Ishii S . (1999). J. Biol. Chem., 274, 8949–8957.

  • Schlessinger J . (2002). Cell, 110, 669–672.

  • Stoker M, Gherardi E, Perryman M and Gray J . (1987). Nature, 327, 239–242.

  • Wakefield LM and Roberts AB . (2002). Curr. Opin. Genet. Dev., 12, 22–29.

  • Wrana JL . (2000a). Cell, 100, 189–192.

  • Wrana JL . (2000b). Sci. STKE, 2000, RE1.

  • Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E and Matsumoto K . (1995). Science, 270, 2008–2011.

  • Zhang Y, Feng XH and Derynck R . (1998). Nature, 394, 909–913.

  • Zhang Y and Derynck R . (1999). Trends Cell Biol., 9, 274–279.

Download references

Acknowledgements

We would like to thank Dr R Derynck (University of California at San Francisco) and Dr S Ohno (Yokohama City University School of Medicine) for providing us with cDNAs encoding human Smad2 and Smad3 and with cDNA encoding dominant-negative form of MEKK-1, respectively. We are grateful to Dr X-F Wang (Duke University) and Drs P ten Dijke and C-H Heldin (Ludwig Institute for Cancer Research) for the generous gifts of p15P113-luc vector and (SBE)4-Luc vector, respectively. We also thank Dr AB Roberts (National Cancer Institute) for helpful discussions concerned with the study. This study was supported by a Grant-in-Aid for scientific research from the Ministry of Education, Science and Culture of Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Koichi Matsuzaki.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mori, S., Matsuzaki, K., Yoshida, K. et al. TGF-β and HGF transmit the signals through JNK-dependent Smad2/3 phosphorylation at the linker regions. Oncogene 23, 7416–7429 (2004). https://doi.org/10.1038/sj.onc.1207981

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207981

Keywords

This article is cited by

Search

Quick links